Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Revenue (2020 - 2025)

BioAtla's Revenue history spans 4 years, with the latest figure at $2.0 million for Q4 2025.

  • For Q4 2025, Revenue changed N/A year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, down 81.82%, while the annual FY2025 figure was $2.0 million, 81.82% down from the prior year.
  • Revenue reached $2.0 million in Q4 2025 per BCAB's latest filing, down from $11.0 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $11.0 million in Q3 2024 to a low of $250000.0 in Q2 2021.
  • Average Revenue over 3 years is $4.4 million, with a median of $2.0 million recorded in 2025.
  • The largest YoY upside for Revenue was 31.58% in 2021 against a maximum downside of 31.58% in 2021.
  • A 3-year view of Revenue shows it stood at $250000.0 in 2021, then surged by 4300.0% to $11.0 million in 2024, then plummeted by 81.82% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Revenue are $2.0 million (Q4 2025), $11.0 million (Q3 2024), and $250000.0 (Q2 2021).